Indeed, in ERα‐positive breast cancer cell lines, IGF‐1R activation rather than IGF‐1R (over)expression stimulated downstream MAPK/PI3K signaling cascades, resulting in cell proliferation despite tamoxifen exposure. The gene discussed is ESR1; the disease is breast carcinoma.